ArticleJournal of managed care & specialty pharmacy2025
The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study.
Andrew S Aguilar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.